Search

Author/Creator Hahn, Noah M.

11. Open‐label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors. Issue 16 (18th May 2016)

Authors:
Graff, Julie N.; Higano, Celestia S.; Hahn, Noah M.; Taylor, Matthew H.; Zhang, Bin; Zhou, Xiaofei; Venkatakrishnan, Karthik; Leonard, E. Jane; Sarantopoulos, John
Journal:
Cancer
Issue:
Volume 122:Issue 16(2016)
Page Start:
2524
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome. Issue 2 (February 2021)

Authors:
Lombardo, Kara A.; Murati Amador, Belkiss; Parimi, Vamsi; Hoffman-Censits, Jean; Choi, Woonyoung; Hahn, Noah M.; Kates, Max; Bivalacqua, Trinity J.; McConkey, David; Hoque, Mohammad O.; Matoso, Andres
Journal:
Applied immunohistochemistry & molecular morphology
Issue:
Volume 29:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗